ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 212446 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 212446; 2) Community: the network communities that were significantly associated with the response to NSC 212446; 3) Molecule: the relationships between components within communities and NSC 212446; 4) MDR: the compounds that were significantly associated with the NSC 212446.

NSC Compound Enrichment Correlation
NSC 134228 .alpha.-Toluenethiol, .alpha.-(nitromethyl)-,acetate (ester) (8CI) 0.00705866970012649 0.32285402
NSC 169774 Bromocriptine methanesulfonate 0.0070787592519192 0.44351184
NSC 237020 TA 1067 0.00707875925191925 0.58826509
NSC 254677 Phomazarin 0.00707875925191925 -0.23680038
NSC 290193 CYCLOSPORIN A 0.00707875925191925 0.28970811
NSC 3061 BW 50-63 0.00707875925191925 0.6995012
NSC 324368 3,5,9-Trioxa-4-phosphaheptacosan-1-aminium, 4-hydroxy-7-methoxy-N,N,N-trimethyl-, hydroxide, inner salt, 4-oxide 0.00707875925191925 0.28194987
NSC 623527 Pyrrolidinium, N-(5-carboxypentyl)-N- [2-[2-[3-(octadecyloxy)-2-[(pyrimidine-2yl)oxy]propyloxy] ethoxy]ethyl]-, inner salt 0.00707875925191925 0.44609543
NSC 631306 cis-Amminedichloro(4-methoxyphenethylamine)platinum(II) 0.00707875925191925 0.51363891
NSC 632620 9-Methoxy-2-[(benzoyloxy)methyl]-5,11-dimethyl- 6H-pyrido[4,3-b]carbazolium iodide 0.00707875925191925 0.47310817
Total:135  Current:36    [First] [Prev] [Next] [Last]